Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MLN-3897 (CCR1 antagonist 10) is an orally active antagonist of CCR1 with a Ki of 2.3 nM for 125I-MIP-1α binding to THP-1 cell membranes. MLN-3897 inhibits Akt signaling and MM cell survival and proliferation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,330.00 | |
50 mg | 8-10 weeks | $ 1,728.00 | |
100 mg | 8-10 weeks | $ 2,595.00 |
Description | MLN-3897 (CCR1 antagonist 10) is an orally active antagonist of CCR1 with a Ki of 2.3 nM for 125I-MIP-1α binding to THP-1 cell membranes. MLN-3897 inhibits Akt signaling and MM cell survival and proliferation. |
Synonyms | AVE9897, AVE 9897, CCR1 antagonist 10, AVE-9897 |
Molecular Weight | 519.03 |
Formula | C30H31ClN2O4 |
CAS No. | 1010731-97-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MLN-3897 1010731-97-1 Immunology/Inflammation Microbiology/Virology CCR AVE9897 MLN3897 AVE 9897 CCR1 antagonist 10 AVE-9897 MLN 3897 inhibitor inhibit